Shares of Owens & Minor, Inc. (NYSE:OMI – Get Free Report) have been given an average recommendation of “Hold” by the eight analysts that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $18.50.
Several research analysts have commented on OMI shares. Barclays dropped their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Citigroup dropped their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird reduced their price target on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Finally, UBS Group dropped their price objective on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, November 5th.
View Our Latest Stock Report on Owens & Minor
Owens & Minor Stock Performance
Owens & Minor (NYSE:OMI – Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same period last year, the business posted $0.44 earnings per share. The firm’s revenue was up 5.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Owens & Minor will post 1.49 EPS for the current year.
Insider Buying and Selling at Owens & Minor
In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.62% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the stock. Deerfield Management Company L.P. Series C increased its holdings in shares of Owens & Minor by 30.6% during the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock worth $86,014,000 after buying an additional 1,493,852 shares in the last quarter. Foundry Partners LLC bought a new stake in Owens & Minor during the 3rd quarter worth approximately $5,238,000. Charles Schwab Investment Management Inc. increased its holdings in Owens & Minor by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,028,236 shares of the company’s stock valued at $31,823,000 after purchasing an additional 187,079 shares in the last quarter. Algert Global LLC increased its holdings in Owens & Minor by 189.4% during the 3rd quarter. Algert Global LLC now owns 276,438 shares of the company’s stock valued at $4,337,000 after purchasing an additional 180,922 shares in the last quarter. Finally, Renaissance Technologies LLC raised its position in Owens & Minor by 16.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock valued at $16,829,000 after purchasing an additional 176,250 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Featured Stories
- Five stocks we like better than Owens & Minor
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Insider Trades May Not Tell You What You Think
- Oilfield Leader SLB: An AI Name You Need to Know
- How Can Investors Benefit From After-Hours Trading
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.